Ranibizumab Alters Levels of Intraocular Soluble Cytokine Receptors in Patients with Diabetic Macular Edema.

Conclusions: Ranibizumab treatment had strong effects on regulating levels of soluble receptors closely linked to IL-1 and IL-6 signaling pathways. Therefore, a complete understanding of the actions of ranibizumab will further the development of additional therapies to support treatment of diabetic macular edema. PMID: 31488015 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31488015?dopt=Abstract

Source: Current Eye Research - September 4, 2019 Category: Opthalmology Authors: Coughlin BA, Guha-Niyogi P, Sikorskii A, Glazer LC, Mohr S Tags: Curr Eye Res Source Type: research